Change in Treatment Plan

Since my last post Jill's condition has continued to improve slowly, but the doctors, anxious to reduce the impact of the graft versus host disease (GVHD), have changed the treatment plan. Yesterday (Monday) they added a new immune suppressing drug that should reduce the GVHD more effectively. In addition, Jill has been added to a trial procedure that involves the introduction of stem cells designed to hasten the repair to GVHD-damaged tissue in Jill's digestive tract. Jill received her first infusion of the stem cells this afternoon.